Drug DiscoveryEvotec axes 400 jobs worldwideAfter the drug discovery specialist Evotec SE lowered its annual forecast and lost almost 75% of its market capitalisation in just eight months, the new CEO, Christian Wojczewski, is taking action and … more ➔
Max Planck Institute for Terrestrial Microbiology/GeiselDecarbonisationNitrogenases also can fix CO2Investigating substrate selectivity of nitrogenase enzymes in phototrophic R. capsulatus bacteria, German microbiologist have found one converting CO2 to formiate and methane opening the way to fossil … more ➔
Sphingotec GmbHDiagnosticsSphingotec secures Series C financingGerman diagnostics specialist SphingoTec GmbH has closed a €5m Series C financing round led by Think.Health Ventures. more ➔
AMRNew antibiotic breaks resistanceA Dutch-German resarch team together with Evotec SE have presented a new class of vancomycin derivatives with good safety profile that kill multi-resistant, Gram-positive bugs. more ➔
Sangamo Therapeutics IncpartnershipRoche inks US$2bn biobucks deal with Sanga...After Sangamo Therapeutics Inc. presented an epigenetic ZFN-based repressor at ASGCT 2024 that reduces the expression of the tau protein in the hippocampus by 95% in Alzheimer’s models, Roche’s US subsidiary … more ➔
Carbios SASBioplasticsCarbios SAS to expand PET recycling portfo...French bioplastics recycling specialist Carbios SAS and British recycling and waste management company FCC Environment want to establish a PET biorecycling facility in the UK. more ➔
Adaütimmune LtdcancerFDA approves cell therapy for solid tumour...The US Food & Drug Administration has granted accelerated approval to Adaptimmune’s Tecelra as the world’s first therapy with genetically engineered T cells to fight a solid tumour. more ➔
Armed Forces Institute of Pathology, AFIPvaccinesValneva licences LimmaTech’s Shigella va...French-Austrian vaccine maker Valneva SE has secured exclusive worldwide rights to commercialise LimmaTech Biologics AG’s S4V Shigella vaccine that will be tested in two Phase II trials starting in … more ➔
SIATfinancingBI Venture Funds invests in oncolytic bact...With an investment of its venture arm (BI-VF), Boehringer Ingelheim underlines its committment to expand the reach of cancer immune therapies. The Series A financing in Chinese Synthetica Pioneering … more ➔
Maxwell Hamilton - wikipedia.orgpartnershipGSK and Flagship Pioneering ink US$7.2bn b...As one of the last Big Pharma companies, GlaxoSmithKline plc has inked a drug discovery licence option deal for up to 10 programmes with US-based biotech platform company supplier Flagship Pioneering … more ➔
Max Planck Institute for Terrestrial Microbiology/Geisel
Sphingotec GmbH
Sangamo Therapeutics Inc
Carbios SAS
Adaütimmune Ltd
Armed Forces Institute of Pathology, AFIP
SIAT
Maxwell Hamilton - wikipedia.org